ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Lantronix stock jumps 15% on strong quarter, raised outlook

Lantronix reported fiscal Q4 revenue of $31.2 million, beating estimates, while narrowing its net loss to $269,000. Management guided for double-digit growth in fiscal 2027.

PA
Priya Anand · Equities & Earnings Desk · 27 Aug 2026 · 23:00 · 1 min read
Share
Lantronix stock jumps 15% on strong quarter, raised outlook

Lantronix Inc. shares surged 15.3% in pre-market trading after the company reported fiscal fourth-quarter revenue of $31.2 million, an 8% increase from the prior year and ahead of Wall Street expectations.

Non-GAAP earnings per share reached $0.04, matching analyst forecasts and rising from a loss of $0.01 in the same period a year earlier. The company’s GAAP net loss narrowed to $269,000 from $2.6 million in the prior-year quarter, while gross margin expanded to 43.7% from 40%.

CEO Saleel Awsare highlighted that Lantronix closed the year with its fifth consecutive quarter of sequential revenue growth. The unmanned systems segment generated $12.6 million in fiscal 2026, exceeding the midpoint of prior guidance.

For fiscal 2027, management projected double-digit revenue growth. First-quarter earnings guidance was set between $0.04 and $0.06 per share, surpassing the $0.04 consensus estimate. The company also maintained a debt-free balance sheet and was recently added to the Russell 3000 Index.

Analysts have taken notice: Canaccord raised its price target to $11, while Jones Trading initiated coverage with a Buy rating. At the time of the report, the NASDAQ was up 1.2% and the S&P 500 gained 0.5%.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT